1.
TCF12 enhances angiogenesis and affects sorafenib response in liver cancer via HIF-1α interaction. Biomol Biomed [Internet]. 2025 Apr. 4 [cited 2025 Aug. 22];25(8):1868–1881. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/12022